CoChat

A Proton MRSI Study of Brain N -Acetylaspartate Level After 12 Weeks of Citalopram Treatment in Drug-Naive Patients With Obsessive-Compulsive Disorder

Jang, Joon Hwan, Kwon, Jun Soo, Jang, Dong Pyo, Moon, Won-Jin, Lee, Jong-Min, Ha, Tae Hyun, Chung, Eun Chul, Kim, In Young, Kim, Sun I. · 2006 · American Journal of Psychiatry
Cited by 63

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective: Reductions in the level of N -acetylaspartate within subcortical structures of patients with obsessive-compulsive disorder (OCD) have been reported in several studies. However, there have been, as yet, no reports regarding N -acetylaspartate levels in the prefrontal cortex of adult drug-naive OCD patients. The authors used proton magnetic resonance spectroscopic imaging ( 1 H-MRSI) to investigate regional N -acetylaspartate level abnormalities and changes after 12 weeks of pharmacotherapy with citalopram in drug-naive OCD patients. Method: Thirteen drug-naive OCD patients and 13 age- and sex-matched healthy comparison subjects were included in this study. N -acetylaspartate levels (obtained from ratios of N -acetylaspartate with creatine, choline, and creatine plus choline) in the prefrontal cortex, parietal cortex, anterior cingulate, posterior cingulate, frontal white matter, and parietal white matter were measured by 1 H-MRSI. In OCD patients, measurements were taken before and after 12 weeks of citalopram treatment. Correlations between N -acetylaspartate concentrations in regions of interest and clinical measures were also assessed. Results: Drug-naive OCD patients exhibited significantly lower N -acetylaspartate levels in the prefrontal cortex, frontal white matter, and anterior cingulate at baseline than did comparison subjects. Significant increases in N -acetylaspartate level were detected in the prefrontal cortex and frontal white matter in OCD patients after 12 weeks of citalopram treatment. Conclusions: These data suggest that reductions in neuronal viability occur in the frontal region of OCD patients and that these reductions may be partly reversible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.2006.163.7.1202

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Dager SR, 1992, Neuropsychopharmacology, 6, 249
  2. 10.1148/radiology.187.1.8451417 · DOI · Paper page
  3. 10.1176/ajp.155.11.1584 · DOI · Paper page
  4. 10.1016/S0925-4927(97)00016-4 · DOI
  5. 10.1016/S0006-3223(99)00286-3 · DOI
  6. 10.1006/nimg.1999.0489 · DOI
  7. 10.1016/S0022-510X(01)00667-0 · DOI
  8. 10.1114/1.1557973 · DOI
  9. 10.1016/S0149-7634(89)80048-X · DOI · Paper page
  10. 10.1097/00001756-199911080-00014 · DOI · Paper page
  11. 10.1159/000017321 · DOI · Paper page
  12. 10.1385/JMN:21:3:185 · DOI
  13. 10.1023/A:1023250721185 · DOI · Paper page
  14. 10.1016/S0197-0186(01)00095-X · DOI · Paper page
  15. 10.1002/(SICI)1522-2594(200002)43:2<244::AID-MRM11>3.0.CO;2-2 · DOI
  16. 10.1212/WNL.49.6.1525 · DOI · Paper page
  17. 10.1002/ana.410400215 · DOI · Paper page
  18. 10.1016/S0006-3223(00)00997-5 · DOI
  19. 10.1001/archpsyc.1987.01800150017003 · DOI · Paper page
  20. 10.1001/archpsyc.1989.01810060038007 · DOI · Paper page
  21. 10.1093/brain/114.5.2191 · DOI · Paper page
  22. 10.1001/archpsyc.1992.01820090018003 · DOI · Paper page
  23. 10.1192/bjp.166.2.244 · DOI · Paper page
  24. 10.1097/01.chi.0000132812.44664.2d · DOI · Paper page
  25. 10.1089/104454603322126322 · DOI · Paper page

Cited by

See all 63

Metadata

Authors
Jang, J. H., Kwon, J. S., Jang, D. P., Moon, W.-J., Lee, J.-M., Ha, T. H., Chung, E. C., Kim, I. Y., & Kim, S. I.
Venue
American Journal of Psychiatry
Published
2006-07
Volume
163
Issue
7
Pages
1202-1207
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W4239154108
Cited by
63
References
3
FWCI
3.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.